Pfizer, Others Tell High Court PTAB Unfair To Patent Owners

By Ryan Davis (October 31, 2016, 9:30 PM EDT) -- Two major drug industry groups and a range of large companies including Pfizer and Qualcomm have urged the U.S. Supreme Court to rule that the same Patent Trial and Appeal Board panel cannot both institute and decide inter partes reviews, calling the system unfair to patent owners....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.

A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!